| Execution period | 12 months |
|---|
NSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.
Q-Line Biotech Ltd: key numbers
- Share price
- ₹525.05
- Market cap
- ₹1,225 Cr
- Revenue (annual)
- ₹341.7 Cr
- Net profit (annual)
- ₹55.72 Cr
- P/E (TTM)
- 22.0×Sector 52.3×
- Promoter holding
- 67.51%
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Q-Line Biotech Ltd
All →Q-Line Biotech Annual General Meeting
Q-Line Biotech Limited held its 16th Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business, including financial statement adoption and director re-appointments.
Q-Line Biotech Annual General Meeting
Q-Line Biotech has sent a letter to shareholders with bounced emails, providing links to the Annual Report and 16th AGM Notice, scheduled for September 30, 2026.
Q-Line Biotech Annual Report
Q-Line Biotech Limited has submitted its Annual Report for the financial year 2025-26. The full document is accessible via the provided company website link.
Q-Line Biotech Board Meeting Outcome
Q-Line Biotech approved the Board's Report, notice for the 16th AGM, and re-appointment of two Whole Time Directors and the Cost Auditor.
Q-Line Biotech Partnership
Q-Line Biotech amended its license agreement with Boule Medical AB, Sweden. The revision includes a 25% reduction in license/royalty costs effective from July 2026.
- From
- Boule Medical AB
- Execution
- 5 years
Q-Line Biotech Other Announcement
Q-Line Biotech Limited filed its quarterly Reconciliation of Share Capital Audit Report, as required under SEBI Regulation 76, for the quarter ended June 30, 2026.
Other other announcement announcements
All →Prizor Viztech Other Announcement
Prizor Viztech reported no deviation in use of preferential issue proceeds to September 2026. Auditors certified utilisation of ₹10.73 crore out of ₹33.75 crore.
- Value
- ₹10.73 Cr
Om Infra Other Announcement
OM Infra Ltd filed its quarterly shareholding pattern for the period ending 30 September 2026. Promoters hold 67.05% of equity, with public shareholding at 32.95%.
Twentyfirst Century Management Services Other Announcement
Twentyfirst Century Management Services files its quarterly shareholding pattern as of 30 June 2026. Promoter and promoter group holding stands at 64.43 percent.
Riyaasat Lifestyle Other Announcement
Riyaasat Lifestyle filed its quarterly shareholding pattern for the period ended September 30, 2026. Promoters and promoter group hold about 73.39% of the 1,07,44,478 shares.
Route Mobile Other Announcement
Route Mobile's IPO proceeds monitoring report shows Rs 1,580.91 million utilised by September 30, 2026. The Rs 650 million Mumbai office purchase remains unutilised.
Vipul Other Announcement
Vipul Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing reports promoter and public holdings without any transaction or corporate event.